About Creso Pharma
Creso Pharma is a Healthcare company based in Perth (Australia) founded in 2015, and was acquired by PharmaCielo in June 2019. Cannabinoid therapeutics are developed for human and veterinary health applications. Creso Pharma has completed 4 acquisitions, including Halucenex, Health House International and Mernova. Its chief executive, as recorded, is Marc Lustig. Its focus areas include HealthTech, Veterinary HealthTech, Health Supplements and Cannabinoid.
Company details
Creso Pharma was founded in 2015 and is headquartered in Perth, Australia. Operations focus on the biotechnology sector, where cannabinoid therapeutics are developed using nanotechnology for both human and veterinary uses. Lead products include a cannabidiol hemp oil-based complementary feed for companion animals and a nutraceutical targeted at human health. The company addresses multiple health purposes through these formulations.
- Headquarters Perth, Australia
- Stage Acquired
- SectorsHealthcare
- Website cresopharma.com
- Social LinkedIn X Facebook
- Acquired by PharmaCielo (Jun 2019)
- InvestorsPharmaCielo
& 1 more
- Investments & AcquisitionsHalucenex
& 3 more
- Acquired byPharmaCielo
(Jun 2019)
Funding Insights of Creso Pharma
- Total Rounds 5
- First Round $5.6M
(Mar 2017)
- Investors Count 1
All 5 funding rounds of Creso Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | Post-IPO | β | β | β | |
| Jun 2020 | $1.42M | Post-IPO | β | β | β |
| Jan 2019 | $3M | Post-IPO | β | β | β |
| Nov 2017 | $17.5M | Post-IPO | β | β | β |
| Mar 2017 | $5.6M | Post-IPO | β | β |
2 investors in total: 2 institutional.
Investors in Creso Pharma
Creso Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include PharmaCielo and EverBlu Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| everblucapital.com | ||||
Medicinal cannabis oil and products are produced in Colombia. | 2014 | pharmacielo.com | Toronto, Canada |
Investor details for Creso Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Creso Pharma
1 people are tracked at Creso Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Marc Lustig | CEO | Leadership |
Complete people profiles for Creso Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Creso Pharma
Creso Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Halucenex, Health House International and Mernova.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cannabis medical services are provided to patients in Australia. | healthhouse.com.au | Perth, Australia | 2014 | May 2023 | β’β’β’β’ | |
Contract manufacturing of plant-based skin care products is provided. | sierrasageherbs.com | Lyons, United States | 2008 | Feb 2022 | $21M | |
Psychedelic drugs for mental illness treatment are developed by Halucenex. | halucenex.com | Windsor, Canada | 2019 | Mar 2021 | β’β’β’β’ | |
Cannabis is produced and supplied by Mernova in Canada. | mernova.com | Canada | 2014 | Jun 2017 | β’β’β’β’ |
Complete acquisition details for Creso Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Creso Pharma
9 dated milestones of Creso Pharma across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Creso Pharma is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $5.6M.
- Acquisition Acquires Mernova.
- Exit Acquired by PharmaCielo.
- Funding Latest funding round, Post-IPO,.
- Acquisition Acquires Halucenex.
- Acquisition Acquires Sierra Sage.
- Acquisition Acquires Health House International.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Creso Pharma
Complete news archive for Creso Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Creso Pharma
Creso Pharma was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Creso Pharma is headquartered in Perth, Australia. It is registered at Perth, Western Australia, Australia.
Marc Lustig is the CEO of Creso Pharma, as recorded in our data.
Creso Pharma was founded in 2015 and is headquartered in Perth, Australia. Operations focus on the biotechnology sector, where cannabinoid therapeutics are developed using nanotechnology for both human and veterinary uses. Lead products include a cannabidiol hemp oil-based complementary feed for companion animals and a nutraceutical targeted at human health. The company addresses multiple health purposes through these formulations.
Creso Pharma has made 4 acquisitions, including Halucenex, Health House International, and Mernova.
Creso Pharma has 2 investors. Key investors include PharmaCielo, and EverBlu Capital.
Yes. Creso Pharma was acquired by PharmaCielo in June 2019.

